Inflammation markers and coronary heart disease

Related Experiment Video

Updated: Oct 2, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

R P Tracy1

  • 1Department of Pathology, University of Vermont College of Medicine, Colchester, USA. russell.tracy@uvm.edu

Current Opinion in Lipidology
|November 11, 1999
PubMed

Insights

Inflammation markers, like C-reactive protein, are linked to atherothrombotic disease and cardiovascular events. Their role as causal factors or indicators requires further study for targeted interventions.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Biomarker Research

Background:

  • Chronic atherothrombotic disease is closely linked to inflammation.
  • Acute phase response proteins (e.g., fibrinogen, C-reactive protein) indicate low-level inflammation.
  • Elevated inflammation markers correlate with subclinical disease and future cardiovascular events.

Purpose of the Study:

  • To explore the association between inflammation markers and atherothrombotic disease.
  • To investigate whether inflammation markers are causal or reflective of cardiovascular disease.
  • To understand the implications of marker levels for predicting future cardiovascular events.

Main Methods:

  • Review of existing evidence linking inflammation markers to atherothrombosis.
  • Analysis of population studies correlating marker levels with subclinical disease and cardiovascular events.
  • Examination of proposed mechanisms for marker involvement in cardiovascular disease.

Main Results:

  • Inflammation markers are associated with subclinical atherothrombotic disease (e.g., carotid wall thickness).
  • Higher inflammation marker levels predict future cardiovascular disease events.
  • Current evidence suggests markers may reflect different stages of the atherothrombotic process.

Conclusions:

  • Inflammation is integral to the chronic atherothrombotic process.
  • The precise role of inflammation markers (causal vs. reflective) in cardiovascular disease needs further elucidation.
  • Understanding marker dynamics is crucial for accurate risk prediction and potential therapeutic strategies.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...